Consolidated Statements of Cash Flows $ in Thousands	12 Months Ended
	Nov. 29, 2020 USD ($)	Nov. 24, 2019 USD ($)	Nov. 25, 2018 USD ($)
Cash Flows from Operating Activities:
Net income	$ (127,141)	$ 394,980	$ 285,244
Adjustments to reconcile net income to net cash provided by operating activities:
Asset Impairment Charges	66,987	2,388	1,552
Depreciation and amortization	141,795	123,942	120,205
Employee benefit plan settlement losses	14,700	0	0
Stock-based compensation	50,947	55,188	18,407
Deferred income taxes	(95,244)	(14,963)	134,258
Other, net	34,892	14,449	(651)
Change in operating assets and liabilities:
Trade receivables	234,217	(82,344)	(60,474)
Inventories	93,096	(22,434)	(147,389)
Accounts payable	12,507	8,887	151,133
Accrued salaries, wages and employee benefits and long-term employee related benefits	(71,137)	(55,363)	(44,887)
Other current and non-current assets	(78,235)	(43,764)	(34,059)
Other current and long-term liabilities	192,202	31,222	(2,968)
Net cash provided by operating activities	469,586	412,188	420,371
Cash Flows from Investing Activities:
Purchases of property, plant and equipment	(130,383)	(175,356)	(159,413)
Payments to Acquire Businesses, Net of Cash Acquired	(54,570)	0	0
Proceeds (payments) on settlement of forward foreign exchange contracts not designated for hedge accounting	12,531	12,166	(19,974)
Payments to acquire short-term investments	(109,663)	(114,247)	0
Proceeds from sale, maturity and collection of short-term investments	93,526	34,094	0
Net cash used for investing activities	(188,559)	(243,343)	(179,387)
Cash Flows from Financing Activities:
Proceeds from issuance of long-term debt	502,500	0	0
Proceeds from senior revolving credit facility	300,000	0	0
Repayments of senior revolving credit facility	(300,000)	0	0
Payment of debt issuance costs	(6,459)	0	0
Short-term credit facilities and borrowings, net	10,045	(23,268)	(1,278)
Proceeds from issuance of common stock and employee stock purchase	8,050	256,391	0
Payments for underwriter commission and other offering costs	0	(19,746)	0
Repurchase of common stock	(56,243)	(3,088)	(27,086)
Shares surrendered for tax withholdings on equity awards	(90,628)	(40,894)	(28,953)
Dividend to stockholders	(63,639)	(113,914)	(90,000)
Other financing, net	(17,631)	(463)	(1,316)
Net cash (used for) provided by financing activities	285,995	55,018	(148,633)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(4,127)	(2,808)	(13,344)
Net increase in cash and cash equivalents and restricted cash	562,895	221,055	79,007
Beginning cash and cash equivalents, and restricted cash	934,753	713,698	634,691
Ending cash and cash equivalents, and restricted cash	1,497,648	934,753	713,698
Less: Ending restricted cash	(493)	(516)	(578)
Ending cash and cash equivalents	1,497,155	934,237	713,120
Noncash Investing Activity:
Property, plant and equipment acquired and not yet paid at end of period	35,994	30,512	23,099
Supplemental disclosure of cash flow information:
Cash paid for interest during the period		54,000	51,200
Income taxes	$ 50,068	$ 96,540	$ 96,277